These findings underscore the diverse biological functions associated with SEPN1 in glioma, encompassing immune-related processes, signaling pathways, and metabolic pathways, which could be pivotal in understanding tumor behavior and developing targeted therapies. The gene discussed is SELENON; the disease is central nervous system cancer.